{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":53,"n_cols":5,"rows_kept":53,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[10,2,10,3],[15,2,15,3],[16,2,16,3],[18,2,18,3],[22,2,22,3],[22,4,22,5],[23,2,23,3],[23,4,23,5],[24,2,24,3],[24,4,24,5],[25,2,25,3],[26,2,26,3],[35,2,35,3],[36,2,36,3],[37,2,37,3],[38,2,38,3],[40,2,40,3],[41,2,41,3],[45,2,45,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910921016603321"]
[null,null,"Autore",null,"Berube David M"]
[null,null,"Titolo",null,"Pandemic Resilience : Vaccination Resistance and Hesitance, Lessons from COVID-19 / / edited by David M. Berube"]
[null,null,"Pubbl/distr/stampa",null,"Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2024"]
[null,null,"ISBN",null,"9783031740626"]
[{"$nulls":4},"3031740629"]
[null,null,"Edizione",null,"[1st ed. 2024.]"]
[null,null,"Descrizione fisica",null,"1 online resource (524 pages)"]
[null,null,"Collana",null,"Risk, Systems and Decisions, , 2626-6725"]
[null,null,"Disciplina",null,"614.4"]
[null,null,"Soggetti",null,"Epidemiology"]
[{"$nulls":4},"Environmental health"]
[{"$nulls":4},"Public health"]
[{"$nulls":4},"Environmental Health"]
[{"$nulls":4},"Public Health"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,"Nota di contenuto",null,"Introduction – Berube – NCSU -- UNIT 1 – WHY HESITANCY? -- 1.1 Vaccinations in the Shadow of Eugenics –Schwartzman, NCSU -- 1.2 Beyond Tuskegee: Trust and African Americans in America’s Health System – Olatunde, NCSU -- 1.3 A Critical Analysis of Black Immunity Myths and their Deadly Consequences - Powell, Morgan State U -- UNIT 2 THE ANTI-SCIENCE AND ANTI-VACCINE MOVEMENTS -- 2.1. The Anti-science movement in 21st century America & Europe - Lunsford, U. Florida -- 2.2. Anti-vaxxers: Wakefield and the Autism Scare - Rodriguez, Weber State University -- 2.3. Cross-Partisan Conspiracy Theories: How “Plandemic” Fueled Vaccine Misinformation - Justice, U. Mississippi & Bricker, U. Kansas -- 2.4. Negative Online Support Groups – Berube, NCSU -- 2.4.1. On-Line Anti-Vaccine Movements -Trend. Luisi, U. Missouri -- 2.4.2. Athletes, Entertainers, and Political Figures: Online Influencers and the Amplification of Anti-Vaccine Voices on Social Media - Eng & Kim, U. Georgia -- UNIT 3 PRELIMINARY DIAGNOSIS -- 3.1. Minds, Made Up or Malleable? Vaccine Refusal at the Eclipse of Public Health Communication—Psychological Reactance Theory - Lee, CUNY -- 3.2. Existential Approaches To Vaccine Hesitancy: Terror Management - Harvell-Bowman, James Madison U -- UNIT 4 SECONDARY RISKS: SIDE EFFECTS AND FATIGUE. - 4.1 Secondary Effects of Covid-19 and Secondary Risks of Covid-19 Responses – "]
[{"$nulls":4},"Ellinport, Klasa, Galaitsi, Well, Jarman & Cummings, U.S. Army ERDC. Side-Effects – Memon, Ohio U -- 4.2.1. Side-eﬀect: Thrombocytopenia - Memon, Ohio U -- 4.2.2. Side-eﬀect: Guillain-Barré syndrome. – Memon, Ohio U. 4.2.3. Side-eﬀect: Myocarditis – Becktel - NCSU -- 4.3. Another Side effect: Vaccination Fatigue – Berube, NCSU -- UNIT 5. SECOND LEVEL DRIVERS IN VACCINE HESITANCY  -- 5.1 Trypanophobia [Fear of needles] and Vaccine Hesitancy - Berube, NCSU -- 5.2 Fear of getting COVID from the vaccine (Breakthrough cases) - Edwards, Tarleton State U -- 5.3 “Long COVID” – Memon, Ohio U -- 5.4 Concerns about the Safety of mRNA Vaccines - Rawlings, U of North Carolina. - UNIT 6. MISCOMMUNICATION CHALLENGES -- 6.1 Aggressive COVID vaccine conspiracies - Lunsford, U. Florida -- 6.2 Exploring Emergency Use Authorizations, Operation Warp Speed, the Case of Mifepristone, and the Dynamics of Agency Decision-Making – Crosswell, U. Nevada, Reno -- 6.3. CDC and COVID Miscommunication, Uncertainty, and Cognitive Closure - Edwards, Tarleton State. - Unit 7. UNCERTAINTIES AND MISUNDERSTANDINGS -- 1 Herd Immunity: Communicating Collective Action to Suppress COVID-19 in Two Nordic countries - Mello, Northeastern U -- 7.2 Wait and see and the Free Riders. - Berube, NCSU -- 7.3 The Politicization of COVID-19 and Implications for Public Health. - Carpenter & Wimpy, Arkansas State -- UNIT 8. CHECKS ON MISINFORMATION -- 8.1 Information Overload and the COVID-19 vaccine - Hatfield, U Houston-Downtown -- 8.2 Using PEN-3 to Evaluate the Effectiveness of the CDC’s COVID-19 Vaccine Communication Toolkit for Community-Based Organizations on Promoting Clinical Trials for African Americans - Powell, Moye & Edmond, Morgan State U. & Howard U -- 8.3. Recommended Approaches For COVID-19 Vaccination/Booster Messaging: An Expert Survey – Crosswell & Duan, U. Nevada, Reno & Bombara, Eastdil Secured -- UNIT 9. MESSAGING -- 9.1 Distrust Medical Professionals and Scientists and their Role in Hesitancy - Rainear, West Chester U of PA -- 9.2 Challenges for Health Departments Communicating on COVID vaccines: A Content Analysis of American Health Department Websites – Seo & Kim, Sam Houston State U -- 9.3. The impact of the Anti-science on general and COVID-19 vaccine refusal across the U.S., Europe, and the low- and middle-income countries of Africa and Latin America - Johnson & Parrish-Sprowl, IUI -- UNIT 10. SPECIAL POPULATIONS 10.1. Parental attitudes and vaccinating their children - Carrion, U. Nevada, Los Vegas -- 10.2. The Unique Challenges Faced by Indigenous Communities during the Pandemic. – Beard and Schoenbauer, U. Minnesota, Duluth, Smiles, U. Victoria, and Villard -- 10.3. Rural and other minority populations – Carpenter & Wimpy, Arkansas State -- UNIT 11. CITIZEN ENGAGEMENT -- The Building is Closed but the Ministry’s Open”: The Role of the Black Church Leaders in Vaccine Communication Through Black Podcast - Powell, Morgan State U. & Sumner, Howard U -- 11.2 Vaccines and Publics: A Variety of Engaging Experiences - Lee, CCNY -- 11.3 Public and Citizen Science - Rainear, West Chester U. of PA -- UNIT 12. RECOMMENDATIONS -- Rebuilding Government Trust: Harnessing Communication for Change. - Becktel, NCSU -- 12.2 Cultivating Epistemic and Argumentative Resilience to Reduce Vaccine Hesitancy – Schwartzman, NCSU -- 12.3 Vaccination is a Public Strategy not a Personal One: Rebuilding Community - Berube, NCSU  -- CONCLUSION – Berube, NCSU."]
[null,null,null,"Sommario/riassunto","This edited volume draws from health communication scholars and offers a depthful examination of the roles vaccination have played and continue to play in contributing to human, community, and transnational protection against infectious diseases. The problems associated with vaccination against infection diseases was made "]
[{"$nulls":4},"abundantly clear during the current pandemic of COVID-19. Vaccines were traced back to Dr. Edward Jenner in the 18th century as a tool to control smallpox in England. Today we have six different categories of vaccines (three seem most controversial today): inactivated, live-attenuated, and messenger RNA (mRNA). We examine the reasons for public reluctance and outright resistance to vaccines examining cognitive biases, communication campaign failures, politicization, misinformation, partisanship, and greed. The healthcare industry has not treated all infected people equally, especially the poor and people of color. This is true in the USA as well as abroad. In the future, we can expect more exotic infections to increase due to globalization, development, and transportation. As climate changes, humans will contact more species carrying many different bacteria and viruses. Advances in medical research have led to increases in the number of vaccinations available to control infection and outbreaks. However, the rates of vaccination have fluctuated over time. A vaccine that is not used is meaningless. To increase vaccination rates, we must learn why the public shies away from vaccinations and under what circumstances. This information will enable us to design more effective messaging and communication campaigns to maximize general resilience. An interactive partnership between providers of healthcare and their patients is a prerequisite to productive and effective vaccination campaigns."]
[null,"2.","Record Nr.",null,"UNINA9911018817003321"]
[null,null,"Autore",null,"Lowen Steven Bradley <1962->"]
[null,null,"Titolo",null,"Fractal-based point processes / / Steven Bradley Lowen, Malvin Carl Teich"]
[null,null,"Pubbl/distr/stampa",null,"Hoboken, N.J., : Wiley-Interscience, 2005"]
[null,null,"ISBN",null,"9786610278398"]
[{"$nulls":4},"9781280278396"]
[{"$nulls":4},"1280278390"]
[{"$nulls":4},"9780470354780"]
[{"$nulls":4},"047035478X"]
[{"$nulls":4},"9780471754725"]
[{"$nulls":4},"0471754722"]
[{"$nulls":4},"9780471754701"]
[{"$nulls":4},"0471754706"]
[null,null,"Descrizione fisica",null,"1 online resource (628 p.)"]
[null,null,"Collana",null,"Wiley Series in Probability and Statistics ; ; v.366"]
[null,null,"Disciplina",null,"519.2/3"]
[null,null,"Soggetti",null,"Point processes"]
[{"$nulls":4},"Fractals"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references (p. 513-565) and index."]
[null,null,"Nota di contenuto",null,"Fractal-Based Point Processes; Preface; Contents; List of Figures; List of Figures; List of Tables; List of Tables; Authors; 1 Introduction; 1.1 Fractals; 1.1 Coastline of Iceland at different scales; 1.2 Point Processes; 1.3 Fractal-Based Point Processes; 1.2 Vehicular-traffic point process; Problems; 1.1 Length of Icelandic coastline at different scales; 1.2 Polygon approximation for perimeter of circle; 2 Scaling, Fractals, and Chaos; 2.1 Dimension; 2.1 Representative objects: measurements and dimensions; 2.2 Scaling Functions; 2.3 Fractals; 2.4 Examples of Fractals"]
[{"$nulls":4},"2.1 Cantor-set construction2.2 Realization of Brownian motion; 2.3 Fern: a nonrandom natural fractal; 2.4 Grand Canyon: a random natural fractal; 2.5 Examples of Nonfractals; 2.5 Realization of a homogeneous Poisson process; 2.6 Deterministic Chaos; 2.6 Nonchaotic system with nonfractal attractor: time course; 2.7 Chaotic system with nonfractal attractor: time course; 2.8 Chaotic system with fractal attractor; 2.9 Chaotic system with fractal attractor: time course; 2.10 Nonchaotic "]
[{"$nulls":4},"system with fractal attractor; 2.7 Origins of Fractal Behavior"]
[{"$nulls":4},"2.11 Nonchaotic system with fractal attractor: time course2.8 Ubiquity of Fractal Behavior; Problems; 3 Point Processes: Definition and Measures; 3.1 Point Processes; 3.2 Representations; 3.1 Point-process representations; 3.3 Interval-Based Measures; 3.2 Rescaled-range analysis: pseudocode; 3.3 Rescaled-range analysis: illustration; 3.4 Detrended fluctuation analysis: pseudocode; 3.4 Count-Based Measures; 3.5 Detrended fluctuation analysis: illustration; 3.6 Construction of normalized variances; 3.5 Other Measures; Problems; 4 Point Processes: Examples; 4.1 Homogeneous Poisson Point Process"]
[{"$nulls":4},"4.2 Renewal Point Processes4.3 Doubly Stochastic Poisson Point Processes; 4.1 Stochastic-rate point processes; 4.4 Integrate-and-Reset Point Processes; 4.5 Cascaded Point Processes; 4.2 Cascaded point process; 4.6 Branching Point Processes; 4.7 Lévy-Dust Counterexample; Problems; 5 Fractal and Fractal-Rate Point Processes; 5.1 Measures of Fractal Behavior in Point Processes; 5.2 Ranges of Power-Law Exponents; 5.3 Relationships among Measures; 5.4 Examples of Fractal Behavior in Point Processes; 5.1 Representative rate spectra; 5.2 Representative normalized Haar-wavelet variances"]
[{"$nulls":4},"5.5 Fractal-Based Point Processes5.3 Normalized Daubechies-wavelet variances; 5.4 Fractal and nonfractal point processes; 5.5 Fractal-rate and nonfractal point processes; Problems; 5.6 Estimated normalized-variance curves; 5.7 Representative interval spectra; 5.8 Representative interval wavelet variances; 5.9 Representative interevent-interval histograms; 5.10 Representative capacity dimensions; 5.11 Generalized dimensions for an exocytic point process; 6 Processes Based on Fractional Brownian Motion; 6.1 Fractional Brownian Motion; 6.1 Realizations of fractional Brownian motion"]
[{"$nulls":4},"6.2 Fractional Gaussian Noise"]
[null,null,null,"Sommario/riassunto","An integrated approach to fractals and point processesThis publication provides a complete and integrated presentation of the fields of fractals and point processes, from definitions and measures to analysis and estimation. The authors skillfully demonstrate how fractal-based point processes, established as the intersection of these two fields, are tremendously useful for representing and describing a wide variety of diverse phenomena in the physical and biological sciences. Topics range from information-packet arrivals on a computer network to action-potential occurrences in a neural"]